Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Filings indexed 826 across all filing types
Latest filing 2019-02-08 Share Issue/Capital Cha…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 janvier 2019" and explicitly states it is published in accordance with the French Commercial Code and AMF regulations to report the number of shares and voting rights as of a specific date (January 31, 2019). This type of periodic disclosure regarding capital structure and voting rights, often triggered by crossing thresholds or required monthly/quarterly, fits best under the category related to significant shareholding notifications or general regulatory updates. Since it specifically details the total number of shares and voting rights (BRUT and NET), it is a notification about the capital structure, which aligns closely with 'Major Shareholding Notification' (MRQ) or a general regulatory filing (RNS). Given the precise nature of reporting share/voting counts required by the AMF, MRQ is the most specific fit, although it is not strictly a notification *of a change* by a major shareholder, but rather a mandatory disclosure of the total count. However, in the context of the provided codes, this is a mandatory disclosure related to share capital/voting rights, which is often grouped with major shareholding reports or general regulatory announcements. Since it is a formal, periodic disclosure of capital structure metrics required by the regulator, and not a general earnings release (ER) or a full annual report (10-K), it is best classified as a specific regulatory disclosure. If MRQ is interpreted broadly as any filing concerning major shareholding metrics, it fits. If not, RNS is the fallback. Given the content is about the total share count and voting rights, which is the basis for monitoring major shareholdings, MRQ is the most appropriate specific code.
2019-02-08 French
Information relating to the total number of voting rights and shares making up the capital
Share Issue/Capital Change Classification · 1% confidence The document is explicitly titled '# PRESS RELEASE' and its primary content is the announcement of the 'Number of shares and voting rights of ADOCIA as of January 31, 2019'. This type of mandatory disclosure, often related to capital structure changes or regulatory reporting thresholds (citing the French 'Code de Commerce' and 'AMF'), is a specific type of regulatory announcement. While it contains share/voting data, it is not a comprehensive financial report (10-K or IR). It is a specific notification regarding the total number of shares and voting rights, which aligns best with a general regulatory filing or a specific capital/share announcement. Given the options, this is a notification of a change/status related to shares and voting rights. It is not a Director's Dealing (DIRS), a Dividend Notice (DIV), or a general Share Issue (SHA/POS). Since it is a formal, periodic disclosure mandated by regulators regarding share count, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-financial report announcement, or potentially 'Declaration of Voting Results & Voting Rights Announcements' (DVA), although DVA usually refers to the *results* of a vote, not the current share count basis. Given the context of mandatory disclosure of share count under AMF rules, RNS is the most appropriate general regulatory filing category for this specific type of periodic update that doesn't fit a more specific financial report code.
2019-02-08 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a press release ("COMMUNIQUE DE PRESSE") dated January 16, 2019, which explicitly confirms the company's financial calendar for the year 2019. This calendar includes dates for the publication of annual results (March 12), Q1 revenue (April 15), the Annual General Meeting (May 16), and interim results (July 17). Since the primary purpose of this document is to announce future dates for various corporate events and filings, including the AGM and the publication of annual results, it functions as an announcement regarding the release schedule of other reports. This aligns best with the 'Report Publication Announcement' (RPA) category, as it is an announcement about when reports will be published, rather than being the full report itself (like 10-K or ER). The mention of the AGM date (May 16) is secondary to the overall purpose of setting the financial schedule.
2019-01-16 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 1% confidence The document is explicitly titled '# PRESS RELEASE' and its primary purpose is to confirm the company's financial calendar for 2019, including dates for financial statement publication and the 'Annual shareholders' meeting'. While it mentions the publication of the '2018 financial statements' and the 'Annual shareholders' meeting' (which relates to AGM-R), the document itself is an announcement *about* future events and report releases, not the full report or the AGM materials themselves. Since it is a general announcement detailing future corporate actions and report releases, it fits best under Report Publication Announcement (RPA) or potentially Regulatory Filings (RNS). Given the specific mention of announcing the publication dates for financial statements and the AGM, RPA is the most precise fit, as it announces the publication of other reports.
2019-01-16 English
Rachat d'actions / Contrat de liquidité Information relative au contrat de liquidité
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and provides a semi-annual update ("Bilan semestriel") on a liquidity contract with Kepler Capital Markets, detailing the cash and shares held as of December 31, 2018, compared to June 30, 2018. This is a specific, periodic announcement regarding financial arrangements or operational status, rather than a full annual report (10-K), a comprehensive interim report (IR), or a standard earnings release (ER). It is a specific regulatory/market communication. Since it is a press release detailing specific financial/contractual status updates, and it doesn't fit perfectly into the other specific categories like DIV, CAP, or DIRS, it falls best under the general regulatory announcement category, RNS, as it is a formal communication to the market about a specific operational/financial metric.
2019-01-10 French
Information relating to the total number of voting rights and shares making up the capital
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and its primary content is the announcement of the "Number of shares and voting rights of ADOCIA as of December 31, 2018." It cites regulatory requirements from the French 'Code de Commerce' and the AMF (Autorité des Marchés Financiers) regarding the disclosure of total outstanding shares and voting rights. This type of periodic disclosure, which reports specific share structure data rather than comprehensive financial results (like 10-K or IR) or management changes (MANG), fits best under the general category of regulatory announcements or specific share/capital updates. Since it is a formal announcement of share structure data required by regulators, it is most closely related to share capital changes or major shareholding notifications. However, it is a mandatory periodic disclosure of the total share count, which is often categorized separately or as a general regulatory filing. Given the options, it is not a standard Earnings Release (ER), Interim Report (IR), or Major Shareholding Notification (MRQ) which usually reports changes by specific shareholders crossing thresholds. It is a mandatory disclosure of the total share base. This type of mandatory, periodic disclosure of share structure data, often required by stock exchanges or regulators, is best classified as a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if interpreted broadly, but RNS is the most appropriate fallback for mandatory, non-core financial/governance disclosures that don't fit elsewhere. Since it is a formal press release announcing a specific regulatory metric, RNS is the most suitable general classification.
2019-01-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.